US 7074924
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted A61KA61K31/519A61K31/52
Quick answer
US patent 7074924 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/519, A61K31/52, A61K31/704, A61K31/7072